A Study of YL202 in Patients With Advanced Solid Tumors

Clinical trial NCT07202364 · RECRUITING

Trial details

NCT number: NCT07202364
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Colorectal Cancer Cervical Cancer Locally Advanced or Metastatic Solid Tumors

Start date: 2025-08-04
Primary completion: 2026-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.